JeanMarie Guenot, who is a business executive, has greatly impacted the health community. She has received her PhD from the University of California, San Francisco. She also received her MBA from the University of Pennsylvania- The Wharton School. Indeed, her ongoing work continues to improve the lives of others. Guenot has over 20 years of experience focused in the pharmaceutical and biotechnology industry. In fact, her experience has allowed her to work in all stages of companies, which has allowed her to really put her skills to use. For instance, she has worked with public and private, pharmaceutical R&D, and business development just to name a few.
For Guenot, it all started with a career at Atlas Venture, where she would manage venture capitalist investments and simultaneously build life science companies. JeanMarie Guenot is dedicated to the advancement of health technology. In fact, Dr. Guenot founded an SKS Ocular, which she also built and ran. The SKS Ocular is a start-up ophthalmic company incubator that is focused on dry AMD, sustained release ocular drug delivery technologies, and macular degeneration. She has also headed other companies such as Hoffmann-La Roche in Basel and Shangai, where she was a business advisor. In addition, she was Vice President of Corporate and Business Development at PDL BioPharma. Here, she led licensing mergers and acquisitions, and alliance management for their commercial product portfolios.
Currently, Guenot is the President and CEO of Amphivena Therapeutics Inc. Amphivena provides services that are focused on drug discoveries that are integral to the advancements of the health industry. Specifically, Amphivena develops tetravalent T-cell redirecting bispecific antibodies. This is for the treatment of hematologic malignancies. In addition, Amphivena Therapeutics currently has a leading drug candidate, AMV-564, which is a CD33/CD3-targeting treatment for acute Myeloid Leukemia or AML.
JeanMarie Guenot has indeed been a key component in creating innovative health technology. Her knowledge and experience is invaluable in that it has continuously aided in the longevity of many people’s lives. Certainly, Guenot has shown the world just how far science can take this world and will continue to push the envelope of innovation for the betterment of the world. Read more about her company’s new partnership on Takeda’s website here.